Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

Ovid Technologies (Wolters Kluwer Health) - Tập 14 Số 6 - Trang 335-342 - 2004
Dyfrig Hughes1, F. Javier Vilar2, Charlotte C Ward1, Ana Alfirevic1, B. Kevin Park1, Munir Pirmohamed1,3,4,5
1Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, L69 3GE, UK and
2Department of Infectious Diseases, North Manchester General Hospital, Manchester, M8 6RL, UK.
3e-mail: [email protected]
4fax: +44 (0)151 794 5540
5requests for reprints to Prof Munir Pirmohamed, Department of Pharmacology and Therapeutics, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK. Tel: +44 (0)151 794 5549

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pirmohamed, 2001, Trends Pharmacol Sci, 22, 298, 10.1016/S0165-6147(00)01717-X

Roses, 2000, Nature, 405, 857, 10.1038/35015728

Wolf, 2000, Br Med J, 320, 987, 10.1136/bmj.320.7240.987

Evans, 1999, Science, 286, 487, 10.1126/science.286.5439.487

Phillips, 2003, Pharmacogenomics, 4, 231, 10.1517/phgs.4.3.231.22691

Hervey, 2000, Drugs, 60, 447, 10.2165/00003495-200060020-00015

Martinez, 2003, N Engl J Med, 349, 1036, 10.1056/NEJMoa021589

Symonds, 2002, Clin Ther, 24, 565, 10.1016/S0149-2918(02)85132-3

Hetherington, 2001, Clin Ther, 23, 1603, 10.1016/S0149-2918(01)80132-6

Peyriere, 2003, Ann Pharmacother, 37, 1392, 10.1345/aph.1C523

Clay, 2002, Clin Ther, 24, 1502, 10.1016/S0149-2918(02)80057-1

Mallal, 2002, Lancet, 359, 727, 10.1016/S0140-6736(02)07873-X

Hetherington, 2002, Lancet, 359, 1121, 10.1016/S0140-6736(02)08158-8

Nolan, 2003, J HIV Ther, 8, 36

Moyle, 2001, Drugs, 61, 19, 10.2165/00003495-200161010-00003

Maher, 2002, AIDS, 16, 2013, 10.1097/00002030-200210180-00005

Bunce, 1995, Tissue Antigens, 46, 355, 10.1111/j.1399-0039.1995.tb03127.x

Staszewski, 2001, JAMA, 285, 1155, 10.1001/jama.285.9.1155

Matherson, 2003, Antivir Ther, 8, 163, 10.1177/135965350300800211

Katlama, 2003, HIV Med, 4, 79, 10.1046/j.1468-1293.2003.00139.x

Fenwick, 2001, Health Econ, 10, 779, 10.1002/hec.635

Risch, 2000, Nature, 405, 847, 10.1038/35015718

Martinelli, 2003, J Thromb Haemost, 1, 410, 10.1046/j.1538-7836.2003.00167.x

Rodriguez-Monguio, 2003, Pharmacoeconomics, 21, 623, 10.2165/00019053-200321090-00002

Fries, 1992, Scand J Rheumatol Suppl, 92, 21, 10.3109/03009749209101385

Roses, 2002, Nat Rev Drug Discov, 1, 541, 10.1038/nrd840

Yang, 2003, Am J Hum Genet, 72, 636, 10.1086/367923